Skip to content

Cart

Your cart is empty

Press Coverage

ISMP Issues Warning about Possible Safety Issues with Newly Authorized Antiviral

News item covers ISMP’s alert regarding Paxlovid for treatment of COVID-19, highlighting that a dose reduction is necessary for patients with moderate renal impairment.

For the full text, visit APhA online.

RETURN TO ISMP HOMEPAGE

Click to return to the ISMP homepage.

LOG IN TO MYECRI

Log in to MyECRI to access your subscriptions and memberships.

REPORT A MEDICATION OR VACCINE ERROR

Your reports help prevent errors and patient harm from reoccurring.

About ISMP

Click to learn about the Institute for Safe Medication Practices.